5 ML calaspargase pegol-mknl 750 UNT/ML Injection [Asparlas]

RxCUI
2121426
RxNorm name
5 ML calaspargase pegol-mknl 750 UNT/ML Injection [Asparlas]
Display name
5 ML calaspargase pegol-mknl 750 UNT/ML Injection [Asparlas]
Full name
5 ML calaspargase pegol-mknl 750 UNT/ML Injection [Asparlas]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761102Asparlascalaspargase pegol-mknl351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
asparlasCALASPARGASE PEGOLServier Pharmaceuticals LLC6585bd0d-bd78-4341-9e87-0f7664821f052024-10-08Warnings, Adverse reactionsExact identifier
rxcui: 2121426

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6585bd0d-bd78-4341-9e87-0f7664821f05ASPARLAS 3,750 UNT in 5 mL Injection [PSN] · 5 ML calaspargase pegol-mknl 750 UNT/ML Injection [Asparlas] [SBD] · Asparlas 3,750 UNT per 5 ML Injection [SY] · Asparlas 750 UNT/ML per 5 ML Injection [SY]412These highlights do not include all the information needed to use ASPARLAS safely and effectively. See full prescribing information for ASPARLAS. ASPARLAS ® (calaspargase pegol-mknl) injection, for intravenous use Initial U.S. Approval: 201820241008